Immunogenicity of Meningococcal ACYW135 Polysaccharide Vaccine in Saudi Children 5 to 9 Years of Age

M. Khalil; Y. Al-Mazrou; P. Balmer; J. Bramwell; N. Andrews; R. Borrow

首页> 外文期刊>Clinical and diagnostic laboratory immunology >Immunogenicity of Meningococcal ACYW135 Polysaccharide Vaccine in Saudi Children 5 to 9 Years of Age

【24h】

Immunogenicity of Meningococcal ACYW135 Polysaccharide Vaccine in Saudi Children 5 to 9 Years of Age

机译：脑膜炎球菌ACYW135多糖疫苗在5至9岁沙特儿童中的免疫原性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Meningococcal tetravalent polysaccharide vaccines were observed to be immunogenic in Saudi children 5 to 9 years of age, with >90% having serum bactericidal antibody titers of ≥8 for serogroups A, Y, and W135; for serogroup C, 77% were putatively protected after vaccination.

机译：在沙特5至9岁的儿童中发现脑膜炎球菌四价多糖疫苗具有免疫原性，其中血清组A，Y和W135的血清杀菌抗体滴度≥8，大于90％。对于C血清群，接种疫苗后77％的人被认为得到了保护。

著录项

来源
《Clinical and diagnostic laboratory immunology》 |2005年第10期|共3页
作者
M. Khalil; Y. Al-Mazrou; P. Balmer; J. Bramwell; N. Andrews; R. Borrow;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类诊断学;
关键词

相似文献

外文文献
中文文献
专利

1. Serologic Responses to ACYW135 Polysaccharide Meningococcal Vaccine in Saudi Children under 5 Years of Age [J] . Y. Al-Mazrou, M. Khalil, R. Borrow, Infection and immunity . 2005,第5期

机译：5岁以下沙特阿拉伯儿童对ACYW135多糖脑膜炎球菌疫苗的血清学反应
2. Safety and Immunogenicity of a Meningococcal Quadrivalent Conjugate Vaccine in Five- to Eight-Year-Old Saudi Arabian Children Previously Vaccinated with Two Doses of a Meningococcal Quadrivalent Polysaccharide Vaccine [J] . Mohamed Khalil, Yagob Al-Mazrou, Helen Findlow, Clinical and vaccine immunology: CVI . 2012,第10期

机译：脑膜炎球菌四价共轭疫苗在五至八岁的沙特阿拉伯儿童中的安全性和免疫原性，该疫苗此前已接种了两剂脑膜炎球菌四价多糖疫苗。
3. Safety and Immunogenicity of a Meningococcal Quadrivalent Conjugate Vaccine in Five- to Eight-Year-Old Saudi Arabian Children Previously Vaccinated with Two Doses of a Meningococcal Quadrivalent Polysaccharide Vaccine [J] . Mohamed Khalil, Yagob Al-Mazrou, Helen Findlow, Clinical and vaccine immunology: CVI . 2012,第10期

机译：脑膜炎球菌四价共轭疫苗在五至八岁的沙特阿拉伯儿童中的安全性和免疫原性，该疫苗此前已接种了两剂脑膜炎球菌四价多糖疫苗。
4. FIRST CHARACTERIZATION OF IMMUNOGENIC CONJUGATES OF VI NEGATIVE SALMONELLA TYPHI O-SPECIFIC POLYSACCHARIDES WITH REPA PROTEIN FOR VACCINE DEVELOPMENT [C] . Salman M, Ali A., Rahman M., Vaccine technology VI . 2016

机译：VI阴性沙门氏菌O型特异性多糖与REPA蛋白的免疫共轭物的第一表征用于疫苗开发
5. Immunogenicity of quadrivalent meningococcal polysaccharide vaccine in children during a mass immunization campaign [D] . King, W. James 1995

机译：儿童大规模免疫接种过程中四价脑膜炎球菌多糖疫苗的免疫原性
6. Immunogenicity of Meningococcal ACYW135 Polysaccharide Vaccine in Saudi Children 5 to 9 Years of Age [O] . M. Khalil, Y. Al-Mazrou, P. Balmer, 2005

机译：脑膜炎球菌ACYW135多糖疫苗在5至9岁沙特儿童中的免疫原性
7. Immunogenicity of Meningococcal ACYW135 Polysaccharide Vaccine in Saudi Children 5 to 9 Years of Age [O] . Khalil, M., Al-Mazrou, Y., Balmer, P., 2005

机译：脑膜炎球菌ACYW135多糖疫苗在5至9岁沙特儿童中的免疫原性

Immunogenicity of Meningococcal ACYW135 Polysaccharide Vaccine in Saudi Children 5 to 9 Years of Age

摘要

著录项

相似文献

相关主题

期刊订阅